A Study to Evaluate the Efficacy and Safety of BuMA Supreme Drug Eluting Stent(DES)

NAActive, not recruitingINTERVENTIONAL

Enrollment

1,000

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

May 31, 2019

Study Completion Date

December 31, 2025

Conditions

Coronary Artery Disease

Interventions

DEVICE

BuMA Supreme

Stent platform: cobalt-chromium alloy

Trial Locations (1)

Zhongshan Hospital, Shanghai

All Listed Sponsors

lead

Sino Medical Sciences Technology Inc.

INDUSTRY

NCT02698852 - A Study to Evaluate the Efficacy and Safety of BuMA Supreme Drug Eluting Stent(DES) | Biotech Hunter | Biotech Hunter